LIPAC Oncology Announces Appointment of Josh Hamermesh to the Board of Directors
- Thursday, May 6, 2021, 7:18
- PR Newswire
- Add a comment
MENLO PARK, Calif., May 6, 2021 /PRNewswire/ — LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Josh Hamermesh as an…
About the Author
admin has written 20781 stories on this site.